{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:21:23Z","timestamp":1792736483082,"version":"4.5.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI182453"],"award-info":[{"award-number":["K23AI182453"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,23]]},"DOI":"10.1093\/cid\/ciag214","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T12:44:08Z","timestamp":1774529048000},"page":"21-24","source":"Crossref","is-referenced-by-count":1,"title":["Beyond Ceftriaxone: The Future of Gonorrhea Diagnosis and Treatment"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4077-3476","authenticated-orcid":false,"given":"Lao-Tzu","family":"Allan-Blitz","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of California, Los Angeles , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey D","family":"Klausner","sequence":"additional","affiliation":[{"name":"Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California , Los Angeles, California ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"2026072309032231600_ciag214-B1","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:82532","volume-title":"Antibiotic resistance threats in the United States, 2019. Report","author":"Centers for Disease Control and Prevention","year":"2019"},{"key":"2026072309032231600_ciag214-B2","author":"United Nations News"},{"key":"2026072309032231600_ciag214-B3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2026072309032231600_ciag214-B4","doi-asserted-by":"crossref","first-page":"e332","DOI":"10.1016\/S1473-3099(23)00479-6","article-title":"The enhanced gonococcal surveillance programme, Cambodia","volume":"23","author":"Ouk","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2026072309032231600_ciag214-B5","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1016\/S1473-3099(24)00230-5","article-title":"Ceftriaxone resistance in Neisseria gonorrhoeae associated with the penA-60.001 allele in Hanoi, Viet Nam","volume":"24","author":"Adamson","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"2026072309032231600_ciag214-B6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1186\/s12879-020-05532-3","article-title":"Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017\u20132019","volume":"20","author":"Adamson","year":"2020","journal-title":"BMC Infect Dis"},{"key":"2026072309032231600_ciag214-B7","doi-asserted-by":"crossref","first-page":"dlae053","DOI":"10.1093\/jacamr\/dlae053","article-title":"High prevalence of ceftriaxone-resistant and XDR Neisseria gonorrhoeae in several cities of Cambodia, 2022\u201323: WHO enhanced gonococcal antimicrobial surveillance programme (EGASP)","volume":"6","author":"Ouk","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026072309032231600_ciag214-B8","first-page":"101125","article-title":"The WHO enhanced gonococcal antimicrobial surveillance programme (EGASP) identifies high levels of ceftriaxone resistance across Vietnam, 2023","volume":"48","author":"Lan","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026072309032231600_ciag214-B9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.15585\/mmwr.mm7312a2","article-title":"Ceftriaxone-resistant gonorrhea \u2013 China, 2022","volume":"73","author":"Zhu","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2026072309032231600_ciag214-B10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.idc.2013.08.004","article-title":"Pelvic inflammatory disease: current concepts in pathogenesis, diagnosis and treatment","volume":"27","author":"Mitchell","year":"2013","journal-title":"Infect Dis Clin North Am"},{"key":"2026072309032231600_ciag214-B11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajog.2016.08.008","article-title":"Sexually transmitted diseases and infertility","volume":"216","author":"Tsevat","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2026072309032231600_ciag214-B12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/antibiotics7030059","article-title":"The growing threat of gonococcal blindness","volume":"7","author":"Dolange","year":"2018","journal-title":"Antibiotics (Basel)"},{"key":"2026072309032231600_ciag214-B13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrmicro794","article-title":"The role of sexually transmitted diseases in HIV transmission","volume":"2","author":"Galvin","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"2026072309032231600_ciag214-B14","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/00042560-200005010-00009","article-title":"Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions","volume":"24","author":"Chesson","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026072309032231600_ciag214-B15","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/OLQ.0000000000000980","article-title":"Proportion of incident human immunodeficiency virus cases among men who have sex with men attributable to gonorrhea and chlamydia: a modeling analysis","volume":"46","author":"Jones","year":"2019","journal-title":"Sex Transm Dis"},{"key":"2026072309032231600_ciag214-B16","author":"Centers for Disease Control and Prevention"},{"key":"2026072309032231600_ciag214-B17","author":"World Health Organization"},{"key":"2026072309032231600_ciag214-B18","author":"World Health Organization"},{"key":"2026072309032231600_ciag214-B19","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1093\/infdis\/jiaf071","article-title":"High prevalence of ceftriaxone-resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023\u20132024","volume":"232","author":"Laumen","year":"2025","journal-title":"J Infect Dis"},{"key":"2026072309032231600_ciag214-B20","first-page":"101709","article-title":"The World Health Organization (WHO) enhanced gonococcal antimicrobial surveillance programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024","volume":"63","author":"Lan","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"2026072309032231600_ciag214-B21","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1093\/cid\/ciaf608","article-title":"How public health surveillance systems can contribute to antimicrobial resistance prevention: the Massachusetts experience","volume":"81","author":"Hsu","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B22","author":"Centers for Disease Control and Prevention: Division of STD Prevention"},{"key":"2026072309032231600_ciag214-B23","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1093\/cid\/ciaf532","article-title":"The invisible tide of Neisseria gonorrhoeae treatment failures: a review and commentary","volume":"81","author":"Fagan","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B24","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/cid\/ciac371","article-title":"Resistance-guided therapy for Neisseria gonorrhoeae","volume":"75","author":"Allan-Blitz","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/OLQ.0000000000000591","article-title":"Wild-type gyrase A genotype of Neisseria gonorrhoeae predicts in vitro susceptibility to ciprofloxacin: a systematic review of the literature and meta-analysis","volume":"44","author":"Allan-Blitz","year":"2017","journal-title":"Sex Transm Dis"},{"key":"2026072309032231600_ciag214-B26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1093\/cid\/ciw864","article-title":"Implementation of a rapid genotypic assay to promote targeted ciprofloxacin therapy of Neisseria gonorrhoeae in a large health system","volume":"64","author":"Allan-Blitz","year":"2017","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/cid\/ciaa596","article-title":"Resistance-guided treatment of gonorrhea: a prospective clinical study","volume":"73","author":"Klausner","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/sextrans-2023-056099","article-title":"Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic","volume":"100","author":"Goldstein","year":"2024","journal-title":"Sex Transm Infect"},{"key":"2026072309032231600_ciag214-B29","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/cid\/ciaf607","article-title":"Cefixime for the treatment of Neisseria gonorrhoeae infections in a setting with increased antimicrobial resistance: a retrospective study in Hanoi, Vietnam","volume":"81","author":"Adamson","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B30","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","article-title":"Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study","volume":"405","author":"Ross","year":"2025","journal-title":"Lancet"},{"key":"2026072309032231600_ciag214-B31","author":"Luckey"},{"key":"2026072309032231600_ciag214-B32","doi-asserted-by":"crossref","first-page":"S249","DOI":"10.1093\/cid\/ciaf524","article-title":"Comparing strategies to introduce two new antibiotics for gonorrhea: a modeling study","volume":"81","author":"Kline","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B33","doi-asserted-by":"crossref","first-page":"e781","DOI":"10.1016\/S2666-5247(23)00145-3","article-title":"Resistance-minimising strategies for introducing a novel antibiotic for gonorrhoea treatment: a mathematical modelling study","volume":"4","author":"Reichert","year":"2023","journal-title":"Lancet Microbe"},{"key":"2026072309032231600_ciag214-B34","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ"},{"key":"2026072309032231600_ciag214-B35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmi.2022.08.008","article-title":"Global prevalence of Neisseria gonorrhoeae infection in pregnant women: a systematic review and meta-analysis","volume":"29","author":"Vaezzadeh","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026072309032231600_ciag214-B36","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1186\/s12879-021-06381-4","article-title":"Gonorrhoea: a systematic review of prevalence reporting globally","volume":"21","author":"Whelan","year":"2021","journal-title":"BMC Infect Dis"},{"key":"2026072309032231600_ciag214-B37","author":"Centers for Disease Control and Prevention"},{"key":"2026072309032231600_ciag214-B38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/OLQ.0000000000002058","article-title":"Takemehome: a novel method for reaching previously untested people through online ordering and self-collect HIV and STI testing","volume":"51","author":"Hecht","year":"2024","journal-title":"Sex Transm Dis"},{"key":"2026072309032231600_ciag214-B39","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.1093\/cid\/ciaf517","article-title":"Current and emerging approaches and technologies for rapid detection of Neisseria gonorrhoeae antimicrobial resistance","volume":"81","author":"Melendez","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026072309032231600_ciag214-B40","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cmi.2024.12.038","article-title":"Viability assessment of Chlamydia trachomatis in men who have sex with men using molecular and culture methods","volume":"31","author":"Rayo","year":"2025","journal-title":"Clin Microbiol Infect"},{"key":"2026072309032231600_ciag214-B41","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(23)00559-5","article-title":"Molecular-viability testing and antimicrobial resistance in sexually transmitted infections","volume":"23","author":"Huston","year":"2023","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciag214\/68516674\/ciag214.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/1\/21\/68516674\/ciag214.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/1\/21\/68516674\/ciag214.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:03:32Z","timestamp":1784811812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/1\/21\/8706800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,12]]},"published-print":{"date-parts":[[2026,7,23]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag214","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,15]]},"published":{"date-parts":[[2026,6,12]]}}}